CHOLMONDELEY PAULA H
CHOLMONDELEY PAULA H's purchase track record
CHOLMONDELEY PAULA H has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/25/2024 | LXEO | $105K | -48.4% | -62.7% | -1.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
LXEO to Acquire Mantle Therapeutics, Expand Friedreich Ataxia Programs. Lexeo Therapeutics announced an agreement to acquire Mantle Therapeutics and enter new collaborations to expand its Friedreich Ataxia portfolio. The company also secured access to Apertura’s TfR1 CapX technology for its treatment programs. These strategic moves aim to strengthen Lexeo's position in the rare disease space, though the stock remains in a technical downtrend.
Transaction History
| TEX | ▲ Buy | Grant | 1,128 | $81K | 6/26/2026 | View on chart |
| LXEO | ▲ Buy | Open Market | 15,000 | $105K | 11/25/2024 | View on chart |
| TEX | ▼ Sell | Open Market | 20,000 | $824K | 11/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Terex Gets Buy Upgrade, Truist Cuts Price Target to $85
Terex received a Buy upgrade, while Truist Securities maintained its Buy rating but lowered its price target to $85. These analyst actions occurred alongside broader industry discussions, including an FTC and USDA request for public comment on agricultural equipment market practices. The stock is currently trading below the average analyst target of $79.09, with recent technical signals indicating a rejection at support levels.
Terex Gets Buy Upgrade, Truist Cuts Price Target to $85. Terex received a Buy upgrade, while Truist Securities maintained its Buy rating but lowered its price target to $85. These analyst actions occurred alongside broader industry discussions, including an FTC and USDA request for public comment on agricultural equipment market practices. The stock is currently trading below the average analyst target of $79.09, with recent technical signals indicating a rejection at support levels.